Abstract: An antenna is provided, comprising a reflector, a director; a first tapered microstrip line, a transition structure, a second tapered microstrip line, and a dipole radiator; wherein the transition structure has a main body of a parallelogram shape having a first side connected to the first tapered microstrip line, a second side opposite to the first side and connected to the second tapered microstrip line, a third side connecting the first side and the second side, and a fourth side connecting the first side and the second side, the third side being opposite to the fourth side; and the transition structure comprises a plurality of teeth connected to and extending away from at least the fourth side of the main body.

Abstract: The device of processing data based on the radio frequency identification includes: a receiving antenna used to receive a first radio frequency signal; a first front-end module electrically connected to the receiving antenna, wherein the first front-end module is used to receive and amplify the first radio frequency signal; a first radio frequency integrated circuit electrically connected to the first front-end module, wherein the first radio frequency integrated circuit is used to demodulate the amplified first radio frequency signal sent by the first front-end module to obtain a first baseband signal; and a baseband chip electrically connected to the first radio frequency integrated circuit, wherein the baseband chip is used to receive the first baseband signal, decode the first baseband signal, and output a data processing result. The present disclosure further provides an office device, an office method, an office apparatus, a storage medium and a program product.

Abstract: The instant invention provides compounds of formula (I) which are PI3K-delta inhibitors, and as such are useful for the treatment of PI3K-delta-mediated diseases such as inflammation, asthma, COPD and cancer.

Abstract: The instant invention provides compounds of formula (I) which are PI3K-delta inhibitors, and as such are useful for the treatment of PI3K-delta-mediated diseases such as inflammation, asthma, COPD and cancer.

Abstract: The present invention provides a method of making 1,1,1,2,3-pentachloropropane comprising: (1) utilizing 1,1,1,3-tetrachloropropane as a raw material and 1,1,1,2,3-pentachloropropane as a solvent to carry out a dehydrochlorination reaction to obtain 1,1,3-trichloropropene, and after the reaction, (2) introducing chlorine gas into the reaction system to carry out a chlorination reaction to obtain 1,1,1,2,3-pentachloropropane. In the present invention, 1,1,1,2,3-pentachloropropane acts as a solvent or a diluent, and may act as an inhibitor to prevent the production of high-boiling residues such as dimers, oligomers or polymers during the dehydrochlorination process. Then, the conversion rate of 1,1,1,3-tetrachloropropane is increased, and consequently, the yield of final product 1,1,1,2,3-pentachloropropane is also increased.